Sponsors (5)
The bill raises shrimp-safety and traceability by requiring inspection-equivalence for imports—protecting consumers and potentially helping domestic producers—while creating risks of higher prices, supply disruptions, extra compliance costs for foreign suppliers, and added enforcement burdens at ports.
Consumers: lower risk of contaminated shrimp because imports from countries without equivalent inspection systems would be refused entry starting one year after enactment.
Small U.S. seafood businesses and producers: clearer equivalence standards may reduce competition from noncompliant imports and improve market opportunities.
Federal and state regulators: FDA will receive more information and formal arrangements with foreign governments about shrimp inspection systems, improving regulatory oversight and traceability.
Importers, U.S. buyers, and consumers: could face supply disruptions or higher shrimp prices if major exporters fail to obtain equivalence and their products are barred.
Foreign governments/exporters and U.S. importers: must compile and share detailed laws and enforcement information, increasing compliance costs and potentially delaying shipments.
Customs/FDA, port operators, and related staff: determining equivalence and refusing noncompliant shipments could burden enforcement resources and slow port operations.
Based on analysis of 2 sections of legislative text.
Introduced May 13, 2025 by Mike Ezell · Last progress May 13, 2025
Requires the FDA to negotiate with foreign governments to confirm that their shrimp inspection systems are equivalent to U.S. standards and to refuse admission of shrimp from countries that do not enter into such agreements or demonstrate equivalence. The Secretary must begin outreach within 180 days and shrimp from noncompliant countries would be treated as adulterated and denied entry starting one year after enactment, with annual reporting to relevant Congressional health and commerce committees.